$1 Million Price Tag in Spotlight as Gene Therapy Becomes Reality 1 234 567

$1 Million Price Tag in Spotlight as Gene Therapy Becomes Reality

voanews.com

Battle lines are being drawn as the first gene therapy for an inherited condition nears the U.S. market, offering hope for people with a rare form of blindness and creating a cost dilemma for health care providers.Spark Therapeutics, whose Luxturna treatment has been recommended for U.S. approval, told investors last week there was a case for valuing it at more than $1 million per patient, although it has yet to set an actual price.However, the U.S. Institute for Clinical and...

Full news

Share:

More:

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567

1 234 567